3DKnee™ System vs. the MJS Knee System
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00764803|
Recruitment Status : Terminated (Corporate decision to discontinue distribution of MJS Knee.)
First Posted : October 2, 2008
Last Update Posted : March 11, 2010
|Condition or disease||Intervention/treatment|
|Rheumatoid Arthritis Traumatic Arthritis Joint Disease Secondary to Osteoarthritis||Device: Encore 3DKnee™ system Device: Encore MJS™ Knee System|
|Study Type :||Observational|
|Actual Enrollment :||27 participants|
|Official Title:||Post-Market Study: The Efficacy of the 3DKnee™ System vs. the MJS Knee System|
|Study Start Date :||January 2008|
|Actual Primary Completion Date :||November 2009|
|Actual Study Completion Date :||December 2009|
Subjects who meet the indications for use and are implanted with the Encore MJS™ Knee System.
Device: Encore MJS™ Knee System
Subjects with rheumatoid arthritis, traumatic arthritis or osteoarthritis who were implanted with the Encore MJS™ Knee system and willing to participate in the study.
Subjects who meet the indications for and are implanted with the Encore 3DKnee™ system.
Device: Encore 3DKnee™ system
Subjects with rheumatoid arthritis, traumatic arthritis or osteoarthritis who were implanted with the Encore 3DKnee™ system and willing to participate in the study.
- The survivorship and efficacy of the Encore 3DKnee™ system with that of the Encore MJS™ Knee System [ Time Frame: 2 year ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00764803
|United States, California|
|Center for Excellence|
|Fresno, California, United States, 93710|
|Principal Investigator:||D. Kevin Lester, M.D.||Center for Excellence|